Davion Healthcare Plc has 2 Schedule 13D or 13G filings on record since 2026-04-17. 1 holder's latest filing reports 5% or more of ordinary shares of (euro)0.01 par value per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Jack Harry Kaye | 41.08% | 10,268,948 | SCHEDULE 13D/A, 2026-08-11 | 2026-08-11 |
Purpose of Transaction (Item 4)
Jack Harry Kaye
On August 11, 2026, Rallinson Corp transferred 1,245,000 Ordinary Shares of the Issuer to Jack Harry Kaye for no consideration, and Rallinson Ltd transferred 3,860,530 Ordinary Shares of the Issuer to Mr. Kaye for no consideration. Mr. Kaye is the sole director, sole shareholder and ultimate beneficial owner of Rallinson Corp and Rallinson Ltd and was the beneficial owner of the Ordinary Shares held through those entities immediately prior to the transfers. The transfers were undertaken solely for the purpose of consolidating Mr. Kaye's holdings of Ordinary Shares into his personal name and converting the manner in which such shares are held from indirect ownership through Rallinson Corp and Rallinson Ltd to direct ownership by Mr. Kaye. No Ordinary Shares were purchased from or sold to any third party in connection with the transfers, no consideration was paid or received, and the transfers did not result in any change in Mr. Kaye's aggregate beneficial ownership or pecuniary interest in the Ordinary Shares. Immediately prior to the transfers, Mr. Kaye beneficially owned an aggregate of 10,268,948 Ordinary Shares, consisting of: (a) 5,163,418 Ordinary Shares held directly by Mr. Kaye; (b) 1,245,000 Ordinary Shares held through Rallinson Corp; and (c) 3,860,530 Ordinary Shares held through Rallinson Ltd. Immediately following completion of the transfers, Mr. Kaye continued to beneficially own the same aggregate 10,268,948 Ordinary Shares, all of which are held …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-08-11; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-04-17 | Jack Harry Kaye | 20.64% | SCHEDULE 13D |
| 2026-08-11 | Jack Harry Kaye | 41.08% | SCHEDULE 13D/A |
Tools for this story
Each opens in a new tab, filled in for Davion Healthcare Plc. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.